Atossa Therapeutics Inc (ATOS)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current ATOS market cap is 181.09M. The company's latest EPS is USD -0.2393 and P/E is -6.10.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -7.1M | -7.79M | -7.47M | -9.02M | -6.98M |
| Net Income | -6.28M | -9.83M | -6.23M | -7.75M | -5.88M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -17.27M | -15.55M | -20.61M | -27.69M | -31.38M |
| Net Income | -17.24M | -22.33M | -20.61M | -26.96M | -30.09M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 116.2M | 108.36M | 101.7M | 96.25M | 91.09M |
| Total Liabilities | 2.94M | 3.48M | 3.44M | 5.24M | 5.33M |
| Total Equity | 113.26M | 104.88M | 98.25M | 91.02M | 85.76M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 14.49M | 42.84M | 141.26M | 123.53M | 96.25M |
| Total Liabilities | 1.33M | 15.67M | 3.13M | 5.57M | 5.24M |
| Total Equity | 13.16M | 27.17M | 138.14M | 117.96M | 91.02M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -7.02M | -11.49M | -15.37M | -20.94M | -4.7M |
| Investing | N/A | -13k | -14k | -14k | -6k |
| Financing | N/A | N/A | -1.48M | -1.48M | 204k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -9.13M | -11.57M | -16.47M | -20.76M | -20.94M |
| Investing | -8k | -9k | -9k | -4.73M | -14k |
| Financing | 11.34M | 38.55M | 113.3M | N/A | -1.48M |
| Market Cap | 181.09M |
| Price to Earnings Ratio | -6.10 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.08 |
| Price to Book Ratio | 2.02 |
| Dividend Yield | - |
| Shares Outstanding | 125.76M |
| Average Volume (1 week) | 785.02k |
| Average Volume (1 Month) | 1.77M |
| 52 Week Change | 37.14% |
| 52 Week High | 2.31 |
| 52 Week Low | 0.62 |
| Spread (Intraday) | 0.08 (5.44%) |
| Company Name | Atossa Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.atossatherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
